Role of p38 MAP kinase in LPS-induced airway inflammation in the rat

British Journal of Pharmacology

Volumn 132, Issue 8, 2001, Pages 1715-1724

  Haddad, El Bdaoui ^a   Birrell, Mark ^b   McCluskie, Kerryn ^b   Ling, Andrea ^a   Webber, Stephen E ^a   Foster, Martyn L ^a   Belvisi, Maria G ^b  

^a Aventis Pharma Ltd   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Airway inflammation; Interleukin 1 ; Lipopolysaccharide; Neutrophilis; p38 MAP kinase; Tumour necrosis factor

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYTOKINE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PICLAMILAST; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CYTOKINE RELEASE; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG LAVAGE; MALE; NEUTROPHILIA; NONHUMAN; NORMAL HUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0035039117     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704022     Document Type: Article

References (66)

1. Specific inhibitors of p38 and extracellular signal-regulated kinase and mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma
2. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function
3. The role of p38 mitogen-activated protein kinase in IL-1β transcription
4. Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide
5. Effect of the p38 kinase inhibitor, SB 203580, on sephadex induced airway inflammation in the rat
6. The role of atopy in grain dust-induced airway disease
7. Both erk and p38 kinases are necessary for cytokine gene transcription
8. T cell proliferation in response to interleukins 2 and 7 requires p38 MAP kinase activation
9. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
10. Transcriptional regulation by MAP kinases
11. Biologic basis for interleukin-1 in disease
12. Effect of the P38 kinase inhibitor, SB 203580. On allergic airway inflammation in the rat
13. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-α: Role of the p38 and p42/44 mitogen-activated protein kinases
14. The pattern of lung injury induced after exposure to tumor necrosis factor-α depends on the route of administration
15. Effects of rolipram on cyclic AMP levels in alveolar macrophages and lipopolysaccharide-induced inflammation in mouse lung
16. Effect of cyclo-oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide-induced neutrophil infiltration in mouse lung
17. Airway oedema and obstruction in guinea pigs exposed to inhaled endotoxin
18. SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo
19. Differential expression and activation of p38 mitogen-activated protein kinase α, β, γ, and δ in inflammatory cell lineages
20. Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation
21. Murine p38-delta mitogen-activated protein kinase, a developmentally regulated protein kinase that is activated by stress and proinflammatory cytokines
22. Pharmacological effects of SB 220025, a selective inhibitor of p38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models
23. Characterization of the structure and function of a new mitogen-activated protein kinase (p38β)
24. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38δ
25. Mitogen-activated protein kinase cascades as regulators of stress responses
26. Tumor necrosis factor induced acute lung leak in rats: Less than with interleukin-1
27. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense
28. Novel homologues of CSBP/p38 MAP kinase: Activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles
29. ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation
30. Inhibitors of serine/threonine kinases
31. Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors
32. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
33. Role of CSBP/p38/RK stress response kinase in LPS and cytokine signaling mechanisms
34. The primary structure, of p38γ: A new member of the p38 group of MAP kinases
35. p38 mitogen-activated protein kinase plays a major role in LPS-induced mRNA expression in monocytes
36. Dose-response relationship to inhaled endotoxin in normal subjects
37. Adrenalectomy permits a late, local TNF-a release in LPS-challenged rat airways
38. Tumor necrosis factor-alpha regulates in vivo intrapulmonary expression of ICAM-1
39. Selective activation and functional significance of p38α mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils
40. Effect of inhaled endotoxin on induced sputum in normal, atopic and atopic asthmatic subjects
41. Glucocorticoid effects in an endotoxin-induced rat pulmonary inflammation model: Differential effects on neutrophil influx, integrin expression, and inflammatory mediators
42. The effect of endotoxin inhalation on airway responsiveness and cellular influx in rats
43. Regulation of tumour necrosis factor production by adrenal hormones in vivo: Insights into the anti-inflammatory activity of rolipram
44. Mechanism of action of bicyclic imidazoles defines a translational regulatory pathway for TNF-α
45. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: Regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels
46. Lipopolysaccharide (LPS) inhalation in healthy subjects causes bronchoalveolar neutrophilia, lymphocytosis, and fibronectin increase
47. Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa
48. Evidence that cyclic AMP phophodiesterase inhibitors suppress TNFa generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer
49. p38-2, a novel mitogen-activated protein kinase with distinct properties
50. Acute lung injury: The role of cytokines in the elicitation of neutrophils
51. Role of endogenous cytokines in endotoxin- and interleukin-1-induced pulmonary inflammatory response and oxygen tolerance
52. Intratracheal injection of endotoxin and cytokines: IX. Contribution of CD11a/ICAM-1 to neutrophil emigration
53. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket
54. Therapeutic intervention in a rat model of ARDS: IV. Phosphodiesterase IV inhibition
55. The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation
56. The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate
57. Intratracheal administration of endotoxin and Cytokines VII. The soluble interleukin-1 receptor and the soluble tumor necrosis factor receptor II (p80) inhibit acute inflammation
58. Intratracheal administration of endotoxin and cytokines IV. The soluble tumor necrosis factor receptor type 1 inhibits acute inflammation
59. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase
60. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat
61. Synergism of intratracheally administered tumor necrosis factor with interleukin-1 in the induction of lung edema in rats
62. Cytokine gene expression after inhalation of corn dust
63. The intratracheal administration of endotoxin: X. Dexamethasone down-regulates neutrophil emigration and cytokine expression in vivo
64. Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein level
65. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site
66. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-α or FMLP stimulation